1227-hivsero.pdf
TRANSCRIPT
-
7/29/2019 1227-hivsero.pdf
1/1
12/11
HIV Testing Algorithm (excludes HIV rapid testing)
Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.MAYO, Mayo Medical Laboratories and the triple-shield Mayo logo are trademarks and/or service marks of MFMER.
HIVE/9333 HIV-1/-2 Antibody Evaluation, SerumI indicated, all other tests listed are
automatically perormed and charged separately
I HIV antibody screen already
perormed order 1 o the ollowing:
WBAR/23878 HIV-1/-2 Antibody
Conrmatory Evaluation, Serum
OR
WBANF/32466 HIV-1/-2
Antibody Conrmatory Without
Immunofuorescence Assay, Serum HIV-1 antibody conrmation by Western blot
HIV Types 1 and 2 Conrmatory Evaluation, Serum
HIV-1/2 antibody screen
HIV-1 inection
HIV-2 inection
Positive
Positive
Negative
Negative
PositiveNegative
HIV-2 Antibody Screen, SerumHIV-1 Antibody Conrmation by
Immunofuorescence, Serum
STOP HIV-1 inection
(low-risk patient)
Negative
*Suspect acute HIV inectionor high-risk patient
HIVQU/81958 HIV-1 RNA Quantication, Plasma
OR
PHIV/88635 HIV-1 Proviral DNA Qualitative
Detection by PCR, Blood
STOP
Repeat HIV-2 antibody screen
HIV2/86702 HIV Type 2 Antibody
Screen, Serum (symptomatic patient)
or HIV2M/60356 HIV-2 Antibody
Screen, Serum (nonsymptomatic
individuals) in 3 months or non-high-
risk patients, i clinically indicated
STOP
Repeat HIVE/9333 in 3 months
or non-high-risk patients, i
clinically indicated
Repeat
serologic testing
HIVE/9333 in
2 to 4 weeks
FHV2Q/91490 HIV-2
DNA/RNA Qualitative
Real-Time PCR
Positive Negative
(high-risk patient)
HIV-2 inection
I suspect
HIV-2
I suspect acute
HIV-2 inection
I suspect
HIV-1
(high-risk patient)
Negative
Indeterminate
or Unreadable
Reactive
Negative
For non-high-risk patients,
repeat serologic HIV
testing HIVE/9333 alone,
in 2 to 4 weeks
I suspect acute
HIV inection or high-
risk patient, see*
I suspect acute
HIV inection or high-
risk patient, see*
HIV 2 Antibody IBL(immunoblot)
Positive
HIV-1 inection
PositiveNegativeI suspect acute HIV inection
or high-risk patient, see*
Repeat serologic testing
HIVE/9333 HIV-1/-2 Antibody
Evaluation, Serum in 2 to 4 weeks
Order Options
Unit Code
Tests Perormed HIVE/9333
WBAR/23878
WBANF/32466
HIV-1-2 Antibody Screen X
HIV Types 1 and 2 Conrmatory Evaluation, Serum X X X
HIV-1 Antibody Conrmation by Western blot X X X
HI V Ty pe 1 Antibo dy Co nrm atio n by Imm unof uor esc en ce , S erum X X
HIV Type 2 Antibody Screen, Serum X X X
HIV 2 Antibody IBL (Immunoblood) X X X
Reviewed 07/2012